May 4 (Reuters) - Actinogen Medical Ltd (ACW) :
- ACTINOGEN MEDICAL LTD - CONDUCTED A REASSESSMENT OF ITS PRIORITIES AND PLANNED EXPENDITURES, RESULTING IN STRATEGIC ADJUSTMENTS
- ACTINOGEN MEDICAL - STRATEGIC ADJUSTMENTS TO PRIORITIZE ALZHEIMER'S DISEASE & MAJOR DEPRESSIVE DISORDER PROGRAMS FOR XANAMEM
- ACTINOGEN MEDICAL - SUSPEND CLINICAL TRIAL OPERATIONS FOR ITS XANAFX FRAGILE X SYNDROME TRIAL & REALLOCATE THOSE RESOURCES TO AD AND MDD
May 4 (Reuters) - Actinogen Medical Ltd (ACW) : ACTINOGEN...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.003(11.1%) |
Mkt cap ! $92.08M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.9¢ | $267.8K | 9.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1189352 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 2232202 | 6 |
View Market Depth
| Last trade - 13.00pm 15/09/2025 (20 minute delay) ? |
| ACW (ASX) Chart |